A Minnesota insurer is taking steps to give financial relief to patients who are struggling with the skyrocketing cost of insulin.
Medica announced this week that both commercial and individual members in Minnesota will pay no more than $25 for a 30-day supply of insulin beginning January 1, 2020. The company insists the new cap will have no impact on premiums for at least the coming year.
“This program is just one example of how Medica works to address the pressing health care issues our members are facing,” said John Naylor, Medica President and Chief Executive Officer. “It is actions like this that our members and customers have come to expect as they put their trust in us and we support them with their health care needs.”
Medica cites its history of providing personalized education and care management programs for members as proof of its commitment to helping patients control their diabetes, which impacts the lives of more than 30 million Americans. According to a report from a working group at the American Diabetes Association (ADA), the list price of insulin has more than doubled in the last decade.